In order to confirm the IFN-γ released from T-cell in cytotoxicity to NSCLC cells, we analyzed IFN-γ release in NSCLC upon the combination treatment with PD-1 mAb and nobiletin (Figure S4). The gene discussed is IFNG; the disease is non-small cell lung carcinoma.